WOBURN, Mass., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today ...
Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced ...
In the spring of 1976, the year America turned 200, Jan Randall, now Jan Crollard, stood under hot stage lights at Pioneer Middle School with a speech about “tomorrow” in ...
Ocular Therapeutix's current wet AMD treatment is dominated by anti-VEGF drugs, with EYLEA holding a 63% global market share in 2024. Read why OCUL stock is a sell.
Have you ever lost a Word document due to an unexpected PC crash? Just this week, I experienced this firsthand. Hours of work vanished when my document disappeared. I didn’t panic, though, because my ...
A recent US Supreme Court victory for retirement investors that lowered the bar for bringing certain ERISA claims is becoming a blessing in disguise for employers seeking to escape litigation.
This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 p.m. to 4 a.m. ET, Sunday through Thursday, when regular markets are closed.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results